Tolerogenic therapies in transplantation.

Journal Article (Journal Article)

Since the concept of immunologic tolerance was discovered in the 1940s, the pursuit of tolerance induction in human transplantation has led to a rapid development of pharmacologic and biologic agents. Short-term graft survival remains an all-time high, but successful withdrawal of immunosuppression to achieve operational tolerance rarely occurs outside of liver transplantation. Collaborative efforts through the NIH sponsored Immune Tolerance Network and the European Commission sponsored Reprogramming the Immune System for Establishment of Tolerance consortia have afforded researchers opportunity to evaluate the safety and efficacy of tolerogenic strategies, investigate mechanisms of tolerance, and identify molecular and genetic markers that distinguish the tolerance phenotype. In this article, we review traditional and novel approaches to inducing tolerance for organ transplantation, with an emphasis on their translation into clinical trials.

Full Text

Duke Authors

Cited Authors

  • Page, EK; Dar, WA; Knechtle, SJ

Published Date

  • 2012

Published In

Volume / Issue

  • 3 /

Start / End Page

  • 198 -

PubMed ID

  • 22826708

Pubmed Central ID

  • PMC3399382

Electronic International Standard Serial Number (EISSN)

  • 1664-3224

Digital Object Identifier (DOI)

  • 10.3389/fimmu.2012.00198


  • eng

Conference Location

  • Switzerland